Immunization strategies forClostridium difficileinfections

A Possible Oligosaccharide-Conjugate Vaccine Candidate for Clostridium difficile Is Antigenic and Immunogenic

(2011) Matthias A. Oberli et al.   CHEMISTRY & BIOLOGY

Encapsulation of Cwp84 into pectin beads for oral vaccination against Clostridium difficile

(2011) Chiara Sandolo et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Immunization of hamsters againstClostridium difficileinfection using the Cwp84 protease as an antigen

(2011) Séverine Péchiné et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

TcdB or not TcdB: a tale of twoClostridium difficiletoxins

(2011) Glen P Carter et al.   Future Microbiology

Immunization with Bacillus Spores Expressing Toxin A Peptide Repeats Protects against Infection with Clostridium difficile Strains Producing Toxins A and B

(2011) Patima Permpoonpattana et al.   INFECTION AND IMMUNITY

A proposed nomenclature for cell wall proteins of Clostridium difficile

(2011) R. P. Fagan et al.   JOURNAL OF MEDICAL MICROBIOLOGY

The host immune response to Clostridium difficile

(2011) C. P. Kelly et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins

(2011) Aimee Shen et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027

(2011) David A. Burns et al.   PLoS One

The Anti-Sigma Factor TcdC Modulates Hypervirulence in an Epidemic BI/NAP1/027 Clinical Isolate of Clostridium difficile

(2011) Glen P. Carter et al.   PLoS Pathogens

The Changing Epidemiology of Clostridium difficile Infections

(2010) J. Freeman et al.   CLINICAL MICROBIOLOGY REVIEWS

Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review

(2010) Marwan S. Abougergi et al.   DIGESTIVE DISEASES AND SCIENCES

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

A toxin contest

(2010) Jimmy D. Ballard   NATURE

The role of toxin A and toxin B in Clostridium difficile infection

(2010) Sarah A. Kuehne et al.   NATURE

Treatment with Monoclonal Antibodies againstClostridium difficileToxins

(2010) Israel Lowy et al.   NEW ENGLAND JOURNAL OF MEDICINE

First Synthesis ofC. difficilePS-II Cell Wall Polysaccharide Repeating Unit

(2010) Elisa Danieli et al.   ORGANIC LETTERS

Clostridial Glucosylating Toxins Enter Cells via Clathrin-Mediated Endocytosis

(2010) Panagiotis Papatheodorou et al.   PLoS One

Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile

(2010) Jordi M. Lanis et al.   PLoS Pathogens

A mariner-Based Transposon System for In Vivo Random Mutagenesis of Clostridium difficile

(2009) S. T. Cartman et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)

(2009) M.P. Bauer et al.   CLINICAL MICROBIOLOGY AND INFECTION

Structure-Function Analysis of Inositol Hexakisphosphate-induced Autoprocessing inClostridium difficileToxin A

(2009) Rory N. Pruitt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Structural insights into the molecular organization of the S-layer fromClostridium difficile

(2009) Robert P. Fagan et al.   MOLECULAR MICROBIOLOGY

Toxin B is essential for virulence of Clostridium difficile

(2009) Dena Lyras et al.   NATURE

Clostridium difficile infection: new developments in epidemiology and pathogenesis

(2009) Maja Rupnik et al.   NATURE REVIEWS MICROBIOLOGY

A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A

(2009) David F. Gardiner et al.   VACCINE

Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)

(2009) Brett A. Leav et al.   VACCINE

Clostridium difficile Toxin CDT Induces Formation of Microtubule-Based Protrusions and Increases Adherence of Bacteria

(2009) Carsten Schwan et al.   PLoS Pathogens

The coming of age of virus-like particle vaccines

(2008) Gary T. Jennings et al.   BIOLOGICAL CHEMISTRY

Clostridium difficile cell-surface polysaccharides composed of pentaglycosyl and hexaglycosyl phosphate repeating units

(2008) Jeyabarathy Ganeshapillai et al.   CARBOHYDRATE RESEARCH

Historical Perspectives on Studies ofClostridium difficileandC. difficileInfection

(2008) John G. Bartlett   CLINICAL INFECTIOUS DISEASES

Active immunization of hamsters againstClostridium difficileinfection using surface-layer protein

(2008) Déirdre B. Ní Eidhin et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1

(2008) T. Akerlund et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Processing of Clostridium difficile toxins

(2008) T. Giesemann et al.   JOURNAL OF MEDICAL MICROBIOLOGY